1-(2,6-Dichloro-4-(trifluoromethyl)phenyl)ethanone, 95.0%, 1g

N-(2-Aminophenyl)-6-[(7-methoxy-4-quinolinyl)oxy]-1-naphthalenecarboxamide, 95%+, 100mg

Solution d'acide citrique, min 46 %, ultra pure, 5 l, emballage plastique.

6-Bromo-2,4-difluoro-3-(trimethylsilyl)benzaldehyde, 98%, 100mg

(R)-2-(PIPERIDIN-3-YL)ACETIC ACID HCL, 97.0%, 250mg

1-(5-Chloro-4-nitro-thiophen-2-yl)-ethanone, 95.0%, 250mg

2-Imidazolidinone>97.0%(GC)25g

2-Methylpyrazolo[1,5-a]pyridine-3-carboxylic acid, 95+%, 1g

Inhibiteur de trypsine, 5 g

Pyrimidine-5-carboxaldehyde, 97.0%, 1g

2-Amino-4-methyl-thiophene-3-carboxylic acid ethyl ester, 98.0%, 25g

2-Chloro-D-mandelic Acid>98.0%(GC)(T)1g

4,4'-(Ethyne-1,2-diyl)dibenzoic acid, 97.0%, 1g